Hikma Pharmaceuticals has still an uptrend and is going toward its highest level.

The company shows strong fundamentals. The growth prospective is encouraging as shown by the revenues expected to almost double in the next 5 years. In addition, the consensus revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.

From a technical viewpoint, the security is trading in a bullish trend in the short and the long term. Increasing moving averages let think there will be no reversal in the coming trading sessions. This growth should help to breakout soon the GBp 1087 medium term resistance in order to reach the trend line.
A long position can be open at the current prices to target GBp 1150 in the next weeks. A stop loss will be placed below GBp 1050.